Loading
HKSEHealthcareMedical - Distribution
Latest quote
HK$0.49
−HK$0.015 · -2.97%
ClouDr Group Limited operates as an investment holding company, providing a diverse range of services within the healthcare sector. The firm supplies hospitals and pharmacies with crucial medical products, including devices like blood glucose meters and vital sign monitors, glucose testing strips, and both over-the-counter and prescription drugs. In addition to physical goods, ClouDr delivers software-as-a-service (SaaS) platforms tailored for healthcare facilities and pharmacies, while also offering digital marketing solutions to pharmaceutical companies. Furthermore, the company facilitates the management of chronic conditions through real-time online consultations, digital health monitoring, and remote prescription and ordering services. Established in 2014, ClouDr Group Limited maintains its primary corporate office in Hangzhou, China.
Latest quote
HK$0.49
−HK$0.015 · -2.97%
Regular session · HKT · Market data may be delayed.
ClouDr Group Limited operates as an investment holding company, providing a diverse range of services within the healthcare sector. The firm supplies hospitals and pharmacies with crucial medical products, including devices like blood glucose meters and vital sign monitors, glucose testing strips, and both over-the-counter and prescription drugs. In addition to physical goods, ClouDr delivers software-as-a-service (SaaS) platforms tailored for healthcare facilities and pharmacies, while also offering digital marketing solutions to pharmaceutical companies. Furthermore, the company facilitates the management of chronic conditions through real-time online consultations, digital health monitoring, and remote prescription and ordering services. Established in 2014, ClouDr Group Limited maintains its primary corporate office in Hangzhou, China.
Day range
Current HK$0.49
52-week range
Current HK$0.49
Regular session · HKT · Market data may be delayed.
ClouDr Group Limited operates as an investment holding company, providing a diverse range of services within the healthcare sector. The firm supplies hospitals and pharmacies with crucial medical products, including devices like blood glucose meters and vital sign monitors, glucose testing strips, and both over-the-counter and prescription drugs. In addition to physical goods, ClouDr delivers software-as-a-service (SaaS) platforms tailored for healthcare facilities and pharmacies, while also offering digital marketing solutions to pharmaceutical companies. Furthermore, the company facilitates the management of chronic conditions through real-time online consultations, digital health monitoring, and remote prescription and ordering services. Established in 2014, ClouDr Group Limited maintains its primary corporate office in Hangzhou, China.
Day range
Current HK$0.49
52-week range
Current HK$0.49
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.62B CNY | 3.49B CNY | 3.69B CNY | 2.99B CNY | 1.76B CNY |
| Cost of goods sold | 848.1M CNY | 2.63B CNY | 2.78B CNY | 2.2B CNY | 1.19B CNY |
| Gross profit | 775.08M CNY | 861.67M CNY | 909.38M CNY | 792.1M CNY | 570.02M CNY |
| Research and development | 46.96M CNY | 75.4M CNY | 88.04M CNY | 114.79M CNY | 236.24M CNY |
| Selling, general, and administrative | 1.02B CNY | 1.04B CNY | 1.17B CNY | 1.27B CNY | 1.06B CNY |
| Operating expenses | 1.63B CNY | 1.24B CNY | 1.22B CNY | 1.38B CNY | 1.27B CNY |
| Interest income | 2.59M CNY | 905K CNY | 2.06M CNY | 3.64M CNY | 12.93M CNY |
| Interest expense | 13.98M CNY | 15.45M CNY | 10.78M CNY | 8.02M CNY | 74.68M CNY |
| Depreciation and amortization | 84.15M CNY | 101.54M CNY | 108.18M CNY | 101.94M CNY | 86.54M CNY |
| Operating income | −853.3M CNY | −376.14M CNY | −314.24M CNY | −591.56M CNY | −695.91M CNY |
| Net income | −924.15M CNY | −516.41M CNY | −323.07M CNY | −1.69B CNY | −4.14B CNY |
Company facts updated Sep 6, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
